Dr. Robert Bermel also discloses research support from Biogen, Genentech, and Novartis, and shares rights to intellectual property underlying the Multiple Sclerosis Performance Test, currently licensed to Qr8 Health and Biogen.
Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis [RAW_REF_TEXT] Gabrielle M. Mey1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Kirsten S. Evonuk1 nAff7, [/RAW_REF_TEXT] [RAW_REF_TEXT] McKenzie K. Chappell1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Laura M. Wolfe1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Rupesh Singh2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Julia C. Batoki2, [/RAW_REF_TEXT] [RAW_REF_TEXT] Minzhong Yu2,3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Neal S. Peachey2,3,4, [/RAW_REF_TEXT] [RAW_REF_TEXT] Bela Anand‑Apte2,3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Robert Bermel5, [/RAW_REF_TEXT] [RAW_REF_TEXT] Daniel Ontaneda5, [/RAW_REF_TEXT] [RAW_REF_TEXT] Kunio Nakamura6, [/RAW_REF_TEXT] [RAW_REF_TEXT] Kedar R. Mahajan1,5 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Tara M. DeSilva ORCID: orcid.org/0000-0002-1212-57621 [/RAW_REF_TEXT] Acta Neuropathologica Communications volume 10, Article number: 104 (2022) Cite this article [RAW_REF_TEXT] 36 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] 3 Altmetric [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] The Original Article was published on 15 June 2022 Correction Open Access Published:15 July 2022 [/RAW_REF_TEXT] Correction to:
Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis [RAW_REF_TEXT] Gabrielle M. Mey1, Kirsten S. Evonuk1 nAff7, McKenzie K. Chappell1, Laura M. Wolfe1, Rupesh Singh2, Julia C. Batoki2, Minzhong Yu2,3, Neal S. Peachey2,3,4, Bela Anand‑Apte2,3, Robert Bermel5, Daniel Ontaneda5, Kunio Nakamura6, Kedar R. Mahajan1,5 & Tara M. DeSilva ORCID: orcid.org/0000-0002-1212-57621 [/RAW_REF_TEXT] Acta Neuropathologica Communications volume 10, Article number: 104 (2022) Cite this article [RAW_REF_TEXT] 36 Accesses 3 Altmetric Metrics details
